What is Ardelyx's deferred revenue, net of current portion?

Ardelyx (ARDX) reported deferred revenue, net of current portion of $13.7M in Q1 2026.

How has Ardelyx's deferred revenue, net of current portion changed year-over-year?

Ardelyx's deferred revenue, net of current portion increased by 64.1% year-over-year, from $8.35M to $13.7M.

Ardelyx ARDX Deferred revenue, net of current portion

Deferred revenue, net of current portion at other companies

Aurinia PharmaceuticalsAUPH

——

Other financials

Income statement

See full

Revenue$94.5M+27.5%

Gross profit$89.7M+45.1%

Operating income-$32.8M+9.8%

Net income-$37.6M+8.6%

EPS (diluted)-$0.15+11.8%

Balance sheet

See full

Cash & equivalents$31.2M+1.3%

Total debt$208.3M+34.3%

Total equity$148.6M+2.0%

Total assets$504.5M+23.0%

Cash flow

See full

Operating cash flow-$32.2M+16.2%

CapEx$69.0K-78.8%

Free cash flow-$32.3M+16.7%

Valuation

See full

Market cap$1.53B+79.5%

Enterprise value$1.71B+74.8%

P/S3.6×+1.2×

Profitability

See full

Gross margin92.5%+7.9pp

Operating margin-25.4%—

Net margin-13.6%—

FCF margin-40.9%—

Returns & leverage

See full

Return on equity-39.5%—

Debt / equity1.4×+0.3×

Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's deferred revenue, net of current portion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ardelyx's deferred revenue, net of current portion?: Ardelyx (ARDX) reported deferred revenue, net of current portion of $13.7M in Q1 2026.
How has Ardelyx's deferred revenue, net of current portion changed year-over-year?: Ardelyx's deferred revenue, net of current portion increased by 64.1% year-over-year, from $8.35M to $13.7M.